Abstract
Background: Idarucizumab is a humanized monoclonal antibody fragment that binds the thrombin-binding site of dabigatran with high affinity, effectively neutralizing its anticoagulant effects. Herein, we present our experience with use of idarucizumab for urgent dabigatran reversal in a patient with hemothorax and perforation of right ventricular free wall by pacemaker lead.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call